Related Experiment Video

Updated: Jun 2, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Diagnosis and management of fetal growth restriction

Jacqueline E A K Bamfo1, Anthony O Odibo

  • 1Obstetrics and Gynecology, London Deanery, London WC1B 5DN, UK.

Journal of Pregnancy
|May 7, 2011
PubMed

Insights

Fetal growth restriction (FGR) poses significant risks to newborns and adults. This review discusses diagnostic and management challenges, exploring technologies to refine care and presenting a clinical pathway for FGR pregnancies.

Area of Science:

  • Perinatal medicine
  • Maternal-fetal medicine
  • Neonatology

Background:

  • Fetal growth restriction (FGR) is a major cause of perinatal mortality and morbidity, and later-life metabolic syndrome.
  • Current understanding of FGR mechanisms has advanced with ultrasound and Doppler technologies.
  • A lack of consistent classification and characterization of FGR severity hinders effective management.

Purpose of the Study:

  • To discuss the diagnostic and management challenges of FGR.
  • To review biophysical, Doppler, biochemical, and molecular technologies for refining FGR management.
  • To present a model clinical management pathway for pregnancies affected by FGR.

Main Methods:

  • Literature review of diagnostic and management strategies for FGR.
  • Discussion of current and emerging technologies (ultrasound, Doppler, biochemical, molecular).
  • Development of a proposed clinical management pathway.

Main Results:

  • Consistent classification and characterization of FGR severity are lacking.
  • Timely intervention in FGR is often based on an "enigma" regarding optimal delivery timing.
  • Various technologies show potential for improving FGR diagnosis and management.

Conclusions:

  • Effective management of FGR relies on structured antenatal surveillance and timely intervention.
  • Further research and standardized approaches are needed to address FGR challenges.
  • The proposed model pathway aims to guide clinical decision-making in FGR management.

More Related Videos

Human Fetal Blood Flow Quantification with Magnetic Resonance Imaging and Motion Compensation06:56

Human Fetal Blood Flow Quantification with Magnetic Resonance Imaging and Motion Compensation

Published on: January 7, 2021

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...